← Back to Search

Visual Stimuli for Space Perception in Vision

N/A
Recruiting
Led By Zijiang He
Research Sponsored by University of Louisville
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults up to 40 years of age
Normal, or corrected-to-normal, visual acuity (at least 20/20)
Must not have
Self-reported history of visual and eye diseases
Timeline
Screening 3 weeks
Treatment Varies
Follow Up druing procedure, an average of 10 sec.
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand how people judge distance while moving, in order to better understand how eye and neurological defects can impair someone's ability to do so.

Who is the study for?
This trial is for adults and children over 18 with good stereo vision (sharp depth perception) and normal or corrected-to-normal eyesight. It's not suitable for those with physical movement issues, pregnant women due to the time needed, or anyone with a history of eye diseases.
What is being tested?
The study tests how well people can judge the location of objects at intermediate distances while moving. Participants will be exposed to visual stimuli that challenge their space perception in a controlled three-dimensional environment.
What are the potential side effects?
Since this trial involves only visual stimuli without any drugs or invasive procedures, side effects are minimal but may include temporary eye strain or headaches from focusing on visual tasks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 40 years old or younger.
Select...
My vision is 20/20, with or without correction.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have a history of eye problems.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure, an average of 10 sec.
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure, an average of 10 sec. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual mechanisms of intermediate distance space perception (distance) before and after self-motion
Visual mechanisms of intermediate distance space perception (height) before and after self-motion.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Visual scencesExperimental Treatment1 Intervention
Lit target locations in visual environment will be varied and subjects' perceived locations will be measured.

Find a Location

Who is running the clinical trial?

University of LouisvilleLead Sponsor
347 Previous Clinical Trials
77,421 Total Patients Enrolled
National Eye Institute (NEI)NIH
555 Previous Clinical Trials
1,407,212 Total Patients Enrolled
1 Trials studying Vision
50 Patients Enrolled for Vision
Zijiang HePrincipal InvestigatorUniversity of Louisville

Media Library

Visual Stimuli for Space Perception Clinical Trial Eligibility Overview. Trial Name: NCT05419713 — N/A
Vision Research Study Groups: Visual scences
Vision Clinical Trial 2023: Visual Stimuli for Space Perception Highlights & Side Effects. Trial Name: NCT05419713 — N/A
Visual Stimuli for Space Perception 2023 Treatment Timeline for Medical Study. Trial Name: NCT05419713 — N/A
~28 spots leftby Jun 2025